Fever, a common clinical symptom, often presents a diagnostic challenge due to its multifaceted etiology. An integrated approach to fever management can enhance patient outcomes, reduce unnecessary investigations, and streamline healthcare resources.
Fevers can be attributed to a broad spectrum of causes, ranging from infectious diseases to non-infectious conditions such as malignancies and autoimmune disorders. A thorough clinical evaluation, including history-taking and physical examination, can provide valuable clues to the underlying cause.
An algorithmic approach, guided by the patient's history, symptoms, and initial investigations, can aid in narrowing the differential diagnosis. This includes considering the duration of fever, associated symptoms, exposure history, and geographical location. Initial investigations typically include a complete blood count, inflammatory markers, and cultures if infection is suspected.
Management should be tailored to the underlying cause of fever. In cases of infection, appropriate antibiotics should be initiated promptly. For non-infectious causes, management of the underlying condition is paramount. Symptomatic treatment of fever with antipyretics should be considered, particularly in patients with discomfort or underlying cardiac conditions.
An integrated, multidisciplinary approach to fever management can optimize patient care. This involves collaboration between infectious disease specialists, rheumatologists, hematologists, and other relevant specialists, depending on the suspected etiology. Regular team discussions can facilitate a comprehensive and holistic approach to patient management.
Managing fever in clinical practice requires a nuanced and integrated approach, taking into account the multifaceted nature of its etiology. By adopting a systematic diagnostic approach, tailoring treatment to the underlying cause, and promoting multidisciplinary collaboration, healthcare professionals can enhance patient outcomes and optimize resource utilization in fever management.
1.
What is a "cancer vaccine" and is it the same as a COVID vaccine?
2.
Advances in "next generation" photoactive cancer therapy
3.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
4.
Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis
5.
FDA Approves New Bladder Cancer First-Line Standard of Care.
1.
Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec
2.
The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v
3.
The latest Hematocrit: An Overview of Red Blood Cell Health
4.
Contemporary Trends in Oncology and Patient Outcomes
5.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation